Lu's Acupuncture and Moxibustion Treatment on Stroke

NCT ID: NCT01806233

Last Updated: 2021-08-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-31

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There will be successive changes in traditional Chinese medicine rehabilitation for stroke patients with limb hemiparetic through therapy of acupuncture and moxibustion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There will be difference in stroke outcomes of ischemic stroke patients with limb hemiparetic from acute to chronic phase under Lu' acupuncture and moxibustion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke Paralysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acupuncture

acupuncture

Group Type EXPERIMENTAL

Acupuncture

Intervention Type PROCEDURE

The treatment group:60 patients receive Acupuncture ,selecting acupoint on:Shenting(DU24), Baihui(DU20), Fengchi(GB20), Hanyan(GB4), Jianyu(LI15), Quchi(LI11),Waiguan(SJ5), Zusanli(ST36), Fenglong(ST40), Xingjian(LV2), Yongquan(KI1), 20minutes each time,ten times / treatment course,two treatment courses in total.

Rehabilitation

rehabilitation exercise

Group Type EXPERIMENTAL

Rehabilitation

Intervention Type PROCEDURE

The matched group:60 patients receive rehabilitation treatment,45 minutes each once,ten time as a period of treatment,two periods of treatment in all.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acupuncture

The treatment group:60 patients receive Acupuncture ,selecting acupoint on:Shenting(DU24), Baihui(DU20), Fengchi(GB20), Hanyan(GB4), Jianyu(LI15), Quchi(LI11),Waiguan(SJ5), Zusanli(ST36), Fenglong(ST40), Xingjian(LV2), Yongquan(KI1), 20minutes each time,ten times / treatment course,two treatment courses in total.

Intervention Type PROCEDURE

Rehabilitation

The matched group:60 patients receive rehabilitation treatment,45 minutes each once,ten time as a period of treatment,two periods of treatment in all.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Rehabilitation treatment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The ages of stroke patients from 40 years old to 70 years old.
* The principle diagnosis according to \<diagnosis-treatment criteria of stroke(trial implementation)\>formulated by Collaboration Acute Brain Diseases of State Administration of Traditional Chinese Medicine in 1996;Ischemic stroke confirmed by CT brain or MRI brain,with stable medical condition and awareness clear.
* Recent stroke from 7 days to 6 months after onset.
* Stroke with limb movement disorder and hypomyotonia,NIHSS≤10,ASHWORTH≤1,GCS\>8.
* Written informed consent by inpatient.

Exclusion Criteria

* Stroke with conscious disturbance or serious cognitive impairment.
* Stroke with limb spasm;ASHWORTH≥1.
* Having cardiac pacemaker,metallic foreign body in treatment position,or hemorrhagic tendency.
* Being oversensitive to electrical stimulus.
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fudan University

OTHER

Sponsor Role collaborator

Shanghai University of Traditional Chinese Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jian Pei, MD

Role: STUDY_CHAIR

Shanghai University of Traditional Chinese Medicine

Yi Wu, MD

Role: STUDY_CHAIR

Huashan Hospital

Jie Jia, MD

Role: STUDY_DIRECTOR

Huashan Hospital

Yi Song, MM

Role: STUDY_DIRECTOR

Shanghai University of Traditional Chinese Medicine

Zouqin Huang, MM

Role: PRINCIPAL_INVESTIGATOR

Shanghai University of Traditional Chinese Medicine

Xiaoxin You, MM

Role: PRINCIPAL_INVESTIGATOR

Shanghai University of Traditional Chinese Medicine

Qinhui FU, MD

Role: PRINCIPAL_INVESTIGATOR

Shanghai University of Traditional Chinese Medicine

Jun Wang, MM

Role: PRINCIPAL_INVESTIGATOR

Shanghai University of Traditional Chinese Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Longhua Hospital,Shanghai University of Traditional Chinese Medicine

Shanghai, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jian Pei, MD

Role: CONTACT

021-64385700 ext. 3534

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Qinhui Fu, MD

Role: primary

+86-21-64385700 ext. 3534

References

Explore related publications, articles, or registry entries linked to this study.

Xu J, Pei J, Fu QH, Zhan YJ. The Prognostic Value of Traditional Chinese Medicine Symptoms in Acute Ischemic Stroke: A Pilot Study. Evid Based Complement Alternat Med. 2020 Jul 15;2020:1520851. doi: 10.1155/2020/1520851. eCollection 2020.

Reference Type DERIVED
PMID: 32733577 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3534123123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Plan of Ischemic Stroke
NCT04953663 UNKNOWN PHASE1/PHASE2